Toggle Main Menu Toggle Search

Open Access padlockePrints

Interleukin-1 participates in the progression from liver injury to fibrosis

Lookup NU author(s): Dr Roben Gieling, Dr Karen Wallace

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Gieling RG, Wallace K, Han Y-P. Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol 296: G1324-G1331, 2009. First published April 2, 2009; doi:10.1152/ajpgi.90564.2008.-Interleukin-1 (IL-1) is rapidly expressed in response to tissue damage; however, its role in coordinating the progression from injury to fibrogenesis is not fully understood. Liver fibrosis is a consequence of the activation of hepatic stellate cells (HSCs), which reside within the extracellular matrix (ECM) of subsinusoids. We have hypothesized that, among the hepatic inflammatory cytokines, IL-1 may directly activate HSCs through autocrine signaling and stimulate the matrix metalloproteinases (MMPs) produced by HSCs within the space of Disse, resulting in liver fibrogenesis. In this study, we first established a temporal relationship between IL-1, MMPs, HSC activation, and early fibrosis. The roles of IL-1 and MMP-9 in HSC activation and fibrogenesis were determined by mice deficient of these genes. After liver injury, IL-1, MMP-9, and MMP-13 levels were found to be elevated before the onset of HSC activation and fibrogenesis. IL-1 receptor-deficient mice exhibited ameliorated liver damage and reduced fibrogenesis. Similarly, advanced fibrosis, as determined by type-I and -III collagen mRNA expression and fibrotic septa, was partially attenuated by the deficiency of IL-1. In the early phase of liver injury, the MMP-9, MMP-13, and TIMP-1 expression correlated well with IL-1 levels. In injured livers, MMP-9 was predominantly colocalized to desminpositive cells, suggesting that HSCs are MMP-producing cells in vivo. MMP-9-deficient mice were partially protected from liver injury and HSC activation. Thus IL-1 is an important participant, along with other cytokines, and controls the progression from liver injury to fibrogenesis through activation of HSCs in vivo.


Publication metadata

Author(s): Gieling RG, Wallace K, Han YP

Publication type: Article

Publication status: Published

Journal: American Journal of Physiology: Gastrointestinal and Liver Physiology

Year: 2009

Volume: 296

Issue: 6

Pages: 1324-1331

ISSN (print): 0193-1857

ISSN (electronic): 1522-1547

Publisher: American Physiological Society

URL: http://dx.doi.org/10.1152/ajpgi.90564.2008

DOI: 10.1152/ajpgi.90564.2008


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
American Liver Foundation
Wright Foundation
R01, AR051558NIDDK
R01, DK069418NIDDK

Share